European Archives - Page 133 of 1345 - European Medical Journal

Air Pollution Exposure Linked to Fibrosis in Older Patients with MASLD

Emerging evidence also implicates air pollution in metabolic disorders common in later life, including dyslipidaemia, weight gain and impaired glucose homeostasis.

Study Finds JAK Inhibitors May Weaken T Cell Response to COVID-19 Vaccination

A new study reveals that rheumatic patients on JAK inhibitors have weaker T cell responses to SARS-CoV-2 vaccination compared to those on TNF inhibitors.

Age Affects Second Cancer Risk After Radioactive Iodine Treatment

A large US study has found that the risk of developing second primary cancers after radioactive iodine treatment for differentiated thyroid cancer varies by age group.

First-Line Malaria Treatment Faces Growing Resistance Threat

A Ugandan trial has found artemether-lumefantrine less effective than other ACTs, with malaria resistance mutations linked to delayed parasite clearance.

Ultrasound and Manometry Provide Insights into Pelvic Floor Disorders

A study of nearly 300 women with obstructive defecation syndrome found that combining transperineal ultrasound with anorectal manometry offers a clearer picture of pelvic floor structure and function.

Combination Immunotherapies Demonstrate Lasting Survival in Melanoma

Biomarker analyses continue to provide insights but have not yet established clear rules for patient selection.

Komal Jhaveri, Breast Medical Oncologist and Clinical Investigator at Memorial Sloan Kettering Cancer Center, New York, USA

Onc Now: Episode 24: What Will the Next Decade of HER2-Targeted Therapy Look Like?

How is the breast cancer landscape evolving, from HER2-low breakthroughs to the future of targeted therapy and precision care?

Remote Management of Cystic Fibrosis with Wearable Sweat Sensor

Wireless sweat patch matches lab accuracy for cystic fibrosis monitoring, promising home-based disease management.

Trial Demonstrates Talazoparib Extends Prostate Cancer Survival

The TALAPRO-2 study enrolled 805 patients from 200 centres across 26 countries, including North America, Europe, Israel, South America, South Africa, and the Asia–Pacific region.

Obesity Limits Full Benefit of Asthma Biologics

A UK registry study shows asthma biologics improve outcomes across BMI groups, but obese patients remain more likely to have uncontrolled disease.